PMID- 8658558 OWN - NLM STAT- MEDLINE DCOM- 19960730 LR - 20190819 IS - 0300-483X (Print) IS - 0300-483X (Linking) VI - 110 IP - 1-3 DP - 1996 Jun 17 TI - Formyl-methionyl-leucyl-phenylalanine and a calcium ionophore A23187 reverse the inhibition of phorbol myristate acetate-induced oxidative burst by linoleic and oleic acid anilides. PG - 39-45 AB - Linoleic and oleic acid anilides profoundly inhibited the production of reactive oxygen metabolites (ROM) in human polymorphonuclear leukocytes (PMNL) induced by a tumor promoter, phorbol myristate acetate (PMA). The addition of a Ca2+ ionophore, A23187, or a chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (fMLP), readily reversed linoleic and oleic acid anilide-induced inhibiton of PMA-evoked respiratory burst in PMNL without affecting PMA-induced respiratory burst. fMLP or A23187 caused a marked increase in the production of ROM in PMNL that did not produce ROM after their co-exposure to PMA and cis-fatty acid anilides. This suggests a role for Ca2+ in this restoration of respiratory burst activity in PMNL. Oleic and linoleic acid anilides enhanced also respiratory burst in PMNL subsequent to their stimulation with fMLP. Interestingly, corresponding fatty acids, linoleic and oleic acid, also inhibited PMA-induced production of ROM in PMNL, but this inhibition was not reversed by A23187 or fMLP. These findings suggest that the aniline moiety of cis-fatty acids significantly modifies the effects of linoleic and oleic acids in the production of ROM in PMNL. Moreover, free intracellular Ca2+ may play a critical role in the activation of PMNL to produce ROM, and in the modulation of the effects of cis-fatty acid anilides. FAU - Heiskanen, K M AU - Heiskanen KM AD - National Public Health Institute, Department of Toxicology, Kuopio, Finland. FAU - Savolainen, K M AU - Savolainen KM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Toxicology JT - Toxicology JID - 0361055 RN - 0 (Anilides) RN - 0 (Carcinogens) RN - 0 (Ionophores) RN - 0 (Linoleic Acids) RN - 0 (Oleic Acids) RN - 0 (Reactive Oxygen Species) RN - 19878-10-5 (linoleylanilide) RN - 37H9VM9WZL (Calcimycin) RN - 5429-85-6 (oleoylanilide) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) RN - SY7Q814VUP (Calcium) SB - IM MH - Anilides/*toxicity MH - Calcimycin/*pharmacology MH - Calcium/metabolism MH - Carcinogens/antagonists & inhibitors/toxicity MH - Drug Synergism MH - Humans MH - Ionophores/*pharmacology MH - Linoleic Acids/*toxicity MH - Luminescent Measurements MH - N-Formylmethionine Leucyl-Phenylalanine/*pharmacology MH - Neutrophils/cytology/*drug effects/metabolism MH - Oleic Acids/*toxicity MH - Reactive Oxygen Species/metabolism MH - Respiratory Burst/*drug effects MH - Tetradecanoylphorbol Acetate/antagonists & inhibitors/toxicity EDAT- 1996/06/17 00:00 MHDA- 1996/06/17 00:01 CRDT- 1996/06/17 00:00 PHST- 1996/06/17 00:00 [pubmed] PHST- 1996/06/17 00:01 [medline] PHST- 1996/06/17 00:00 [entrez] AID - 0300-483X(96)03320-3 [pii] AID - 10.1016/0300-483x(96)03320-3 [doi] PST - ppublish SO - Toxicology. 1996 Jun 17;110(1-3):39-45. doi: 10.1016/0300-483x(96)03320-3.